Nyce Commodities & Derivatives Profile
Key Indicators
- Authorised Capital ₹ 8.50 M
as on 05-12-2024
- Paid Up Capital ₹ 8.50 M
as on 05-12-2024
- Company Age 27 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 2.38 Cr
as on 05-12-2024
- Revenue -134.61%
(FY 2021)
- Profit -245.77%
(FY 2021)
- Ebitda -27.09%
(FY 2021)
- Net Worth -53.49%
(FY 2021)
- Total Assets -69.53%
(FY 2021)
About Nyce Commodities & Derivatives
The Corporate was formerly known as Nyce Pharma Limited. The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 8.50 M and a paid-up capital of Rs 8.50 M.
The company has closed loans amounting to ₹2.38 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Harsh Goyal, Yash Goyal, and Ramesh Goyal serve as directors at the Company.
- CIN/LLPIN
U74900HR1997PLC058202
- Company No.
058202
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
13 Aug 1997
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Gurugram, Haryana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Nyce Commodities & Derivatives?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Harsh Goyal | Director | 13-Aug-1997 | Current |
Yash Goyal | Director | 12-Jan-2001 | Current |
Ramesh Goyal | Director | 13-Aug-1997 | Current |
Financial Performance of Nyce Commodities & Derivatives.
Nyce Commodities & Derivatives Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 134.61% decrease. The company also saw a substantial fall in profitability, with a 245.77% decrease in profit. The company's net worth observed a substantial decline by a decrease of 53.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Nyce Commodities & Derivatives?
In 2021, Nyce Commodities & Derivatives had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Nyce Securities & Derivatives LimitedActive 15 years 6 months
Harsh Goyal, Yash Goyal and 1 more are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Punjab & Sind Bank Creation Date: 01 Mar 2007 | ₹8.50 M | Satisfied |
Punjab & Sind Bank Creation Date: 20 Feb 2007 | ₹8.50 M | Satisfied |
Punjab & Sind Bank Creation Date: 11 Apr 2003 | ₹5.00 M | Satisfied |
How Many Employees Work at Nyce Commodities & Derivatives?
Unlock and access historical data on people associated with Nyce Commodities & Derivatives, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nyce Commodities & Derivatives, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nyce Commodities & Derivatives's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.